Herzschrittmachertherapie und Elektrophysiologie最新文献

筛选
英文 中文
[Surgical closure of the left atrial appendage for thromboembolism prophylaxis]. [预防血栓栓塞的左心房附件手术关闭]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-05-30 DOI: 10.1007/s00399-025-01086-6
Ioana Geisler, Thomas Pühler, Stephan Ensminger, Buntaro Fujita
{"title":"[Surgical closure of the left atrial appendage for thromboembolism prophylaxis].","authors":"Ioana Geisler, Thomas Pühler, Stephan Ensminger, Buntaro Fujita","doi":"10.1007/s00399-025-01086-6","DOIUrl":"https://doi.org/10.1007/s00399-025-01086-6","url":null,"abstract":"<p><strong>Background: </strong>The left atrial appendage (LAA) is the origin of thrombi in patients with atrial fibrillation (AF). Various techniques are available for surgical LAA occlusion. Current guidelines recommend surgical LAA closure as concomitant procedure in patients undergoing cardiac surgery or endoscopic or hybrid ablation for AF.</p><p><strong>Objectives: </strong>This review article summarizes the current scientific evidence regarding surgical LAA closure and provides an outlook into its potential role in the future.</p><p><strong>Materials and methods: </strong>A literature review was performed for LAA closure, indications, techniques, clinical outcomes, and ongoing studies.</p><p><strong>Results: </strong>Different techniques are performed for surgical LAA closure. In a large randomizes study surgical LAA closure was associated with a reduction in thromboembolism in patients with AF. There are ongoing studies that examine the potential role of surgical LAA closure in patients with sinus rhythm and increased risk for stroke.</p><p><strong>Conclusions: </strong>Surgical closure as a concomitant procedure in patients with AF undergoing cardiac surgery is now well established. It is unclear whether these patients require anticoagulation after successful closure. Currently, a few randomized trials are ongoing to evaluate whether prophylactic surgical LAA closure in patients with sinus rhythm and increased risk for stroke effectively reduces the incidence of stroke. At present, there are no data that support surgical LAA closure in patients with sinus rhythm and low risk for stroke.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144188537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Implantable cardioverter-defibrillators in patients with left ventricular assist devices : Current controversies]. [植入式心律转复除颤器在左心室辅助装置患者中的应用:目前的争议]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-05-22 DOI: 10.1007/s00399-025-01081-x
Barbara Linz, Thomas Pühler, Julia Vogler, Christina Paitazoglou, Roland Richard Tilz, Stephan Ensminger, Buntaro Fujita
{"title":"[Implantable cardioverter-defibrillators in patients with left ventricular assist devices : Current controversies].","authors":"Barbara Linz, Thomas Pühler, Julia Vogler, Christina Paitazoglou, Roland Richard Tilz, Stephan Ensminger, Buntaro Fujita","doi":"10.1007/s00399-025-01081-x","DOIUrl":"https://doi.org/10.1007/s00399-025-01081-x","url":null,"abstract":"<p><strong>Background: </strong>Left ventricular assist devices (LVAD) are used to treat patients with advanced heart failure. A significant fraction of these patients simultaneously fulfill the indication for an implantable cardioverter-defibrillator (ICD).</p><p><strong>Objectives: </strong>It is currently unclear whether patients require an ICD after LVAD implantation. In addition, it remains uncertain whether patients with an LVAD are suitable candidates for a subcutaneous ICD (S-ICD).</p><p><strong>Materials and methods: </strong>The aforementioned questions were addresses using studies, case reports, and our own experience.</p><p><strong>Results: </strong>Studies have yielded varying findings on the above question. While some investigations suggest that an ICD may also be beneficial for LVAD patients, other studies highlight potential risks with limited benefit. This underscores the complexity of clinical decision-making in this specific patient cohort. S‑ICDs can suffer from significant functional impairments after LVAD implantation, making this combination controversial.</p><p><strong>Conclusions: </strong>Due to the inconclusiveness of current studies, a general recommendation regarding the role of an ICD (both conventional and S‑ICD) after LVAD implantation cannot be established at this time. Therefore, it should involve individualized and interdisciplinary decision making.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144121523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rhythm therapy for congenital heart defects with implantable electronic devices]. 【植入式电子设备治疗先天性心脏缺陷】。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-05-21 DOI: 10.1007/s00399-025-01080-y
Peter A Zartner
{"title":"[Rhythm therapy for congenital heart defects with implantable electronic devices].","authors":"Peter A Zartner","doi":"10.1007/s00399-025-01080-y","DOIUrl":"https://doi.org/10.1007/s00399-025-01080-y","url":null,"abstract":"<p><p>Patients with congenital heart defects have an increased indication rate for pacemaker systems and implantable cardioverter defibrillators (ICD), which however are not designed for children. Therefore, the combination of selected materials is essential for long-term and safe therapy. Epimyocardial systems are the best option for neonates and infants, as well as patients with Fontan circulation who do not have systemic venous access to the heart. For most other patients, transvenous systems are advantageous because the leads and batteries last longer and are easier to adjust as the patient grows. To avoid vascular complications, only the thinnest leads should be used and broken leads should be explanted. Telemetric monitoring is urgently indicated for these patients in order to detect rhythm or system disturbances at an early stage.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144112404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful pulsed field ablation of pulmonary veins in an atrial fibrillation patient with situs inversus totalis. 心房颤动全倒位患者肺静脉脉冲场消融的成功。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-05-13 DOI: 10.1007/s00399-025-01077-7
Endrik Wolff, Sybille Brandner, Mihai Hasmasan, Wishnu Mahardhika, Andreas Goette
{"title":"Successful pulsed field ablation of pulmonary veins in an atrial fibrillation patient with situs inversus totalis.","authors":"Endrik Wolff, Sybille Brandner, Mihai Hasmasan, Wishnu Mahardhika, Andreas Goette","doi":"10.1007/s00399-025-01077-7","DOIUrl":"https://doi.org/10.1007/s00399-025-01077-7","url":null,"abstract":"<p><p>Situs inversus (situs transversus) is a rare congenital anomaly with an incidence of ∼0.01% in the general population. Catheter ablation of atrial fibrillation (AF) in patients with situs inversus totalis poses technical challenges. Here, the first case of successful pulsed field ablation (PFA) using the circular array catheter (PulseSelect™ PFA System; Medtronic) in an AF patient with situs inversus totalis is presented.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Next generation-Education and training in rhythmology : Perspectives from Heidelberg]. [下一代-节奏学的教育和训练:海德堡的观点]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-05-12 DOI: 10.1007/s00399-025-01079-5
Ann-Kathrin Rahm, Christine Mages, Niklas Vetter, Barbara Milles, Florian Kehrle, Pascal Schlegel, Eva Hofmann, Samantha Fischer, Benjamin Meder, Norbert Frey, Patrick Lugenbiel
{"title":"[Next generation-Education and training in rhythmology : Perspectives from Heidelberg].","authors":"Ann-Kathrin Rahm, Christine Mages, Niklas Vetter, Barbara Milles, Florian Kehrle, Pascal Schlegel, Eva Hofmann, Samantha Fischer, Benjamin Meder, Norbert Frey, Patrick Lugenbiel","doi":"10.1007/s00399-025-01079-5","DOIUrl":"https://doi.org/10.1007/s00399-025-01079-5","url":null,"abstract":"<p><p>Education and training in the fields of cardiology and electrophysiology are undergoing significant changes due to new and digital teaching formats. This article illustrates current developments and challenges in integrating innovative teaching methods into the education of aspiring cardiologists and electrophysiologists at our center in Heidelberg, Germany. With the ongoing digitization of the educational system, virtual simulations, interactive learning platforms, and online-based training programs are becoming increasingly important. These new teaching formats enable both effective and flexible knowledge transfer as well as practical experiences in a complex medical specialty. The focus of this review is on presenting various digital teaching approaches at the University Hospital in Heidelberg. By providing a comprehensive overview of current trends and future potentials of these teaching formats, this article aims to contribute to the promotion of new and integrative teaching methods in the fields of cardiology and electrophysiology.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144050571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The present and future of cardiological telemonitoring in Europe: a statement from seven European countries. 欧洲心脏病远程监测的现在和未来:来自七个欧洲国家的声明。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-04-08 DOI: 10.1007/s00399-025-01076-8
Thomas M Helms, Giuseppe Boriani, Hans-Peter Brunner-La Rocca, Cedric Klein, Friedrich Koehler, Paweł Krzesiński, Yannick Maaser, Anne Neumann, Jose L Merino, Carsten Schultz, David Jay Wright, Bettina Zippel-Schultz, Gerhard Hindricks
{"title":"The present and future of cardiological telemonitoring in Europe: a statement from seven European countries.","authors":"Thomas M Helms, Giuseppe Boriani, Hans-Peter Brunner-La Rocca, Cedric Klein, Friedrich Koehler, Paweł Krzesiński, Yannick Maaser, Anne Neumann, Jose L Merino, Carsten Schultz, David Jay Wright, Bettina Zippel-Schultz, Gerhard Hindricks","doi":"10.1007/s00399-025-01076-8","DOIUrl":"https://doi.org/10.1007/s00399-025-01076-8","url":null,"abstract":"<p><p>Cardiovascular diseases remain one of the leading causes of death worldwide, placing a significant burden on individuals, families and healthcare systems. Telemedicine, in particular remote monitoring of patients with cardiovascular diseases, reduces this burden as it links the continuous monitoring of the health status with individual education and adaptation of the therapy to the needs of the patients. This improves patient outcomes and facilitates access to specialised healthcare services, independent of time and distance. Furthermore, telemedicine enables improvements in efficiency and promotes patients' self-care. However, the widespread adoption of remote patient monitoring faces several hurdles. A round table of experts from seven European countries (France, Germany, Italy, Poland, Spain, the Netherlands and the United Kingdom) reviewed the current state of telemedicine within the participating countries in order to learn from each other with an impetus for European co-operation. The creation of reliable regulations, overcoming regional differences, the redefinition of roles and processes, the personalisation of healthcare services, the promotion of innovation and research, the use of artificial intelligence and, finally, the efficient management and safeguarding of healthcare data were identified as key levers for further development of telemedicine. This discussion paper emphasises the need for cross-national research activities, involving all stakeholders, such as researchers, industry and patients, to foster the integration of telemedicine in clinical pathways.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143813019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Letter to the editor]. [给编辑的信]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-03-01 Epub Date: 2025-03-03 DOI: 10.1007/s00399-025-01073-x
Walter Seeger
{"title":"[Letter to the editor].","authors":"Walter Seeger","doi":"10.1007/s00399-025-01073-x","DOIUrl":"10.1007/s00399-025-01073-x","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"96-97"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Catheter ablation in patients with heart failure-who benefits?] 心衰患者的导管消融——谁受益?]
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-03-01 Epub Date: 2025-01-30 DOI: 10.1007/s00399-025-01066-w
Leonard Bergau, Vanessa Sciacca, Christian Sohns
{"title":"[Catheter ablation in patients with heart failure-who benefits?]","authors":"Leonard Bergau, Vanessa Sciacca, Christian Sohns","doi":"10.1007/s00399-025-01066-w","DOIUrl":"10.1007/s00399-025-01066-w","url":null,"abstract":"<p><p>Atrial fibrillation (AF) ablation is associated with a lower likelihood of death and surgical heart failure (HF) interventions in patients with HF. This effect is mainly driven by reduced all cause and cardiovascular death following ablation. Ablation also results in improved left ventricular (LV) function, decreased AF burden and AF regression. The accumulated evidence contributed substantially to a class 1 indication for AF ablation in patients with AF and HF with reduced ejection fraction in the 2023 ACC/AHA/ACCP/HRS guidelines. Risk scores like the CASTLE-HTx risk score may help to identify patients with HF who will particularly benefit from catheter ablation. The absolute benefit of catheter ablation is more pronounced in high-risk patients and is sustained over time. Catheter ablation should be considered as first-line therapy with a definitive class 1 indication for many patients with HF, particularly those with advanced HF.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"3-9"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143069630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Letter to the editor]. [致编辑的信]
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-03-01 Epub Date: 2025-03-03 DOI: 10.1007/s00399-025-01074-w
Bernd Lemke
{"title":"[Letter to the editor].","authors":"Bernd Lemke","doi":"10.1007/s00399-025-01074-w","DOIUrl":"10.1007/s00399-025-01074-w","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"98"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EP-Ausbildung in Österreich. 澳大利亚的教育。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2025-03-01 DOI: 10.1007/s00399-024-01056-4
{"title":"EP-Ausbildung in Österreich.","authors":"","doi":"10.1007/s00399-024-01056-4","DOIUrl":"https://doi.org/10.1007/s00399-024-01056-4","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":"36 1","pages":"99-100"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143558626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信